SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016667
Filing Date
2022-08-11
Accepted
2022-08-11 08:20:43
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-20220630.htm   iXBRL 10-Q 2589432
2 EX-31.1 rapt-ex31_1.htm EX-31.1 21453
3 EX-31.2 rapt-ex31_2.htm EX-31.2 21464
4 EX-32.1 rapt-ex32_1.htm EX-32.1 23726
  Complete submission text file 0000950170-22-016667.txt   7771613

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rapt-20220630_def.xml EX-101.DEF 137349
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rapt-20220630_pre.xml EX-101.PRE 237208
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rapt-20220630_cal.xml EX-101.CAL 44008
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rapt-20220630_lab.xml EX-101.LAB 322360
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rapt-20220630.xsd EX-101.SCH 37105
53 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20220630_htm.xml XML 1426814
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 221153817
SIC: 2834 Pharmaceutical Preparations